I hope others are more successful than we were here at crossroads virology where we blasted off last March and put 11 patients on cabenuva and lost nearly $75000 before the calendar year was done getting way underpaid by BCBS, Aetna, and others. I had an employee spending 8-16 hours a week on these while getting threat emails from the wholesaler we owed money to.
After working with ViiV support on a weekly basis, we still couldn’t even break even and now we have had to switch them all back to pills after using almost all of our 340b money to cover the losses. We tried switching from “buy and bill” to “brown bagging” ( specialty pharmacy bills for and sends the Cabenuva), but now Walgreens has told us they can’t work with Cabenuva either!
We realized this was hopeless when we met with an infusion company who said they had hundreds of clients they worked with and none were making money with Cabenuva.
It’s a great drug but I can’t help anybody when we have to go bankrupt.
Hard to believe we thought we were being heroic but now we are just feeling broke and stupid. The huge financial loss and inability to provide it has demoralized all of us badly.
Crossroads Virology medical director
Sent from my iPad
Sent: 4/26/2022 12:30:00 PM
From: Dan Ebeling
Subject: Introducing the Long Acting Agents Discussion Forum
I’m very excited to announce that we’ve just launched our second discussion board on the Academy Communities platform, the Long Lasting Agents Discussion Forum. This discussion thread is focused specifically on Long Lasting Antiretroviral Agents (LAA) and is the first in a set of resources for patients and providers that will be coming out over the next year around this topic.
If you are currently prescribing LAAs, or hope to in the future, I encourage you to join the conversation in this forum. By joining, you’ll get a Daily Digest e-mail with activity updates, similar to the one you get for the Academy Exchange.
Joining the LAA Discussion Forum is easy. Simply navigate to the main Academy Communities page, log in, then select “JOIN” next to the LAA Discussion Forum on the left side.
If you have any questions about joining this community, please don’t hesitate to contact me directly at firstname.lastname@example.org.
I hope to see you in the LAA Discussion Forum!
Dan Ebeling (he/him)
Academy Communities Admin
Director of Credentialing and Technology
+1 (202) 659-0699